{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:38:45Z","timestamp":1773297525521,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T00:00:00Z","timestamp":1534377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T00:00:00Z","timestamp":1534377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We investigated whether changes in MetS status over two years modify the 10-year risk of CKD and proteinuria. A prospective cohort study was conducted in 7,251 subjects without CKD at baseline. We categorized subjects according to MetS status over two years: non-MetS (no MetS at either visit), intermittent MetS (positive for MetS at one assessment), and persistent MetS (positive for MetS at two assessments). The hazard ratio (HR) of new-onset CKD over 10-year was calculated using Cox models. During the 10-year follow-up period, 923 (12.7%) developed CKD. Compared to the non-MetS group, the fully adjusted HR for new-onset CKD was the highest in the persistent MetS group (HR, 1.53; 95% CI, 1.23\u20131.90), followed by the intermittent MetS group (HR, 1.29; 95% CI, 1.04\u20131.59) (P for trend &lt;0.001). The HR for developing proteinuria was 1.79 (95% CI, 1.15\u20132.79) in the persistent MetS group and 0.70 (95% CI, 0.42\u20131.19) in the intermittent MetS group when the non-MetS group was considered as the reference group. Temporal changes in MetS status over two years influenced the 10-year risk of incident CKD and proteinuria. Our findings suggest that monitoring and strictly controlling MetS are important in preventing renal function decline.<\/jats:p>","DOI":"10.1038\/s41598-018-29958-7","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T09:21:51Z","timestamp":1533892911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Metabolic syndrome status over 2 years predicts incident chronic kidney disease in mid-life adults: a 10-year prospective cohort study"],"prefix":"10.1038","volume":"8","author":[{"given":"So Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hun Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun jeong","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taehwa","family":"Go","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Ryong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jang Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5445-8007","authenticated-orcid":false,"given":"Ji Hye","family":"Huh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,16]]},"reference":[{"key":"29958_CR1","first-page":"S1","volume":"39","author":"National Kidney, F","year":"2002","unstructured":"National Kidney, F. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39, S1\u2013266 (2002).","journal-title":"Am J Kidney Dis"},{"key":"29958_CR2","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1046\/j.1523-1755.1999.00773.x","volume":"56","author":"BF Culleton","year":"1999","unstructured":"Culleton, B. F. et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56, 2214\u20132219, https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00773.x (1999).","journal-title":"Kidney Int"},{"key":"29958_CR3","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley, R. N., Parfrey, P. S. & Sarnak, M. J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32, S112\u2013119 (1998).","journal-title":"Am J Kidney Dis"},{"key":"29958_CR4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1681\/ASN.V133745","volume":"13","author":"P Muntner","year":"2002","unstructured":"Muntner, P., He, J., Hamm, L., Loria, C. & Whelton, P. K. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13, 745\u2013753 (2002).","journal-title":"J Am Soc Nephrol"},{"key":"29958_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/jama.286.4.421","volume":"286","author":"HC Gerstein","year":"2001","unstructured":"Gerstein, H. C. et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286, 421\u2013426 (2001).","journal-title":"JAMA"},{"key":"29958_CR6","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1093\/ndt\/gfr154","volume":"26","author":"SW Lee","year":"2011","unstructured":"Lee, S. W. et al. Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korean National Health and Nutrition Examination Survey (KNHANES). Nephrol Dial Transplant 26, 3975\u20133980, https:\/\/doi.org\/10.1093\/ndt\/gfr154 (2011).","journal-title":"Nephrol Dial Transplant"},{"key":"29958_CR7","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ki.2015.230","volume":"88","author":"KT Mills","year":"2015","unstructured":"Mills, K. T. et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int 88, 950\u2013957, https:\/\/doi.org\/10.1038\/ki.2015.230 (2015).","journal-title":"Kidney Int"},{"key":"29958_CR8","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.metabol.2016.11.003","volume":"67","author":"JH Huh","year":"2017","unstructured":"Huh, J. H. et al. An association of metabolic syndrome and chronic kidney disease from a 10-year prospective cohort study. Metabolism 67, 54\u201361, https:\/\/doi.org\/10.1016\/j.metabol.2016.11.003 (2017).","journal-title":"Metabolism"},{"key":"29958_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/DMSO.S94772","volume":"9","author":"P Walden","year":"2016","unstructured":"Walden, P. et al. Assessing the incremental benefit of an extended duration lifestyle intervention for the components of the metabolic syndrome. Diabetes Metab Syndr Obes 9, 177\u2013184, https:\/\/doi.org\/10.2147\/DMSO.S94772 (2016).","journal-title":"Diabetes Metab Syndr Obes"},{"key":"29958_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13098-016-0182-0","volume":"8","author":"H Ohnishi","year":"2016","unstructured":"Ohnishi, H. et al. Impact of longitudinal status change in metabolic syndrome defined by two different criteria on new onset of type 2 diabetes in a general Japanese population: the Tanno-Sobetsu Study. Diabetol Metab Syndr 8, 64, https:\/\/doi.org\/10.1186\/s13098-016-0182-0 (2016).","journal-title":"Diabetol Metab Syndr"},{"key":"29958_CR11","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1253\/circj.CJ-17-0513","volume":"82","author":"H Hu","year":"2018","unstructured":"Hu, H. et al. Metabolic Syndrome Over 4 Years Before the Onset of Cardiovascular Disease- Nested Case-Control Study. Circ J 82, 430\u2013436, https:\/\/doi.org\/10.1253\/circj.CJ-17-0513 (2018).","journal-title":"Circ J"},{"key":"29958_CR12","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1001\/archinte.165.8.947","volume":"165","author":"J Lea","year":"2005","unstructured":"Lea, J. et al. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Arch Intern Med 165, 947\u2013953, https:\/\/doi.org\/10.1001\/archinte.165.8.947 (2005).","journal-title":"Arch Intern Med"},{"key":"29958_CR13","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/ki.1996.111","volume":"49","author":"K Iseki","year":"1996","unstructured":"Iseki, K., Iseki, C., Ikemiya, Y. & Fukiyama, K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 49, 800\u2013805 (1996).","journal-title":"Kidney Int"},{"key":"29958_CR14","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2337\/dc10-2109","volume":"34","author":"S Lim","year":"2011","unstructured":"Lim, S. et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 34, 1323\u20131328, https:\/\/doi.org\/10.2337\/dc10-2109 (2011).","journal-title":"Diabetes Care"},{"key":"29958_CR15","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/sj.ki.5000050","volume":"69","author":"H Tanaka","year":"2006","unstructured":"Tanaka, H., Shiohira, Y., Uezu, Y., Higa, A. & Iseki, K. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 69, 369\u2013374, https:\/\/doi.org\/10.1038\/sj.ki.5000050 (2006).","journal-title":"Kidney Int"},{"key":"29958_CR16","first-page":"305","volume":"21","author":"K Iseki","year":"2008","unstructured":"Iseki, K. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem. J Nephrol 21, 305\u2013312 (2008).","journal-title":"J Nephrol"},{"key":"29958_CR17","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1291\/hypres.30.937","volume":"30","author":"M Tozawa","year":"2007","unstructured":"Tozawa, M. et al. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res 30, 937\u2013943, https:\/\/doi.org\/10.1291\/hypres.30.937 (2007).","journal-title":"Hypertens Res"},{"key":"29958_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1017\/S1368980016001920","volume":"20","author":"M Watanabe","year":"2017","unstructured":"Watanabe, M. et al. Effects of a lifestyle modification programme to reduce the number of risk factors for metabolic syndrome: a randomised controlled trial. Public Health Nutr 20, 142\u2013153, https:\/\/doi.org\/10.1017\/S1368980016001920 (2017).","journal-title":"Public Health Nutr"},{"key":"29958_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/0886022X.2014.964140","volume":"37","author":"JH Lin","year":"2015","unstructured":"Lin, J. H. et al. Association between management of metabolic syndrome and progression of early-stage chronic kidney disease: an observational cohort study. Ren Fail 37, 29\u201336, https:\/\/doi.org\/10.3109\/0886022X.2014.964140 (2015).","journal-title":"Ren Fail"},{"key":"29958_CR20","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/ki.1997.260","volume":"51","author":"LG Hunsicker","year":"1997","unstructured":"Hunsicker, L. G. et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51, 1908\u20131919 (1997).","journal-title":"Kidney Int"},{"key":"29958_CR21","first-page":"289","volume":"16","author":"DC Muller","year":"1996","unstructured":"Muller, D. C., Elahi, D., Tobin, J. D. & Andres, R. The effect of age on insulin resistance and secretion: a review. Semin Nephrol 16, 289\u2013298 (1996).","journal-title":"Semin Nephrol"},{"key":"29958_CR22","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1046\/j.1523-1755.2002.00626.x","volume":"62","author":"M Tozawa","year":"2002","unstructured":"Tozawa, M. et al. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int 62, 1743\u20131749, https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00626.x (2002).","journal-title":"Kidney Int"},{"key":"29958_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0002-9343(82)90490-9","volume":"72","author":"TH Hostetter","year":"1982","unstructured":"Hostetter, T. H., Rennke, H. G. & Brenner, B. M. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72, 375\u2013380 (1982).","journal-title":"Am J Med"},{"key":"29958_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4093\/dmj.2012.36.4.255","volume":"36","author":"S Sasaki","year":"2012","unstructured":"Sasaki, S. & Inoguchi, T. The role of oxidative stress in the pathogenesis of diabetic vascular complications. Diabetes Metab J 36, 255\u2013261, https:\/\/doi.org\/10.4093\/dmj.2012.36.4.255 (2012).","journal-title":"Diabetes Metab J"},{"key":"29958_CR25","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/hr.2016.192","volume":"40","author":"H Itoh","year":"2017","unstructured":"Itoh, H., Kurihara, I., Miyashita, K. & Tanaka, M. Clinical significance of \u2018cardiometabolic memory\u2019: a systematic review of randomized controlled trials. Hypertens Res 40, 526\u2013534, https:\/\/doi.org\/10.1038\/hr.2016.192 (2017).","journal-title":"Hypertens Res"},{"key":"29958_CR26","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2337\/dc16-0024","volume":"39","author":"Action to Control Cardiovascular Risk in Diabetes Follow-On Eye Study, G. and the Action to Control Cardiovascular Risk in Diabetes Follow-On Study, G","year":"2016","unstructured":"Action to Control Cardiovascular Risk in Diabetes Follow-On Eye Study, G. and the Action to Control Cardiovascular Risk in Diabetes Follow-On Study, G. Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study. Diabetes Care 39, 1089\u20131100, https:\/\/doi.org\/10.2337\/dc16-0024 (2016).","journal-title":"Diabetes Care"},{"key":"29958_CR27","doi-asserted-by":"publisher","first-page":"694","DOI":"10.2337\/dc15-2322","volume":"39","author":"MG Wong","year":"2016","unstructured":"Wong, M. G. et al. Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON. Diabetes Care 39, 694\u2013700, https:\/\/doi.org\/10.2337\/dc15-2322 (2016).","journal-title":"Diabetes Care"},{"key":"29958_CR28","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1161\/CIRCULATIONAHA.105.548461","volume":"112","author":"J Bosch","year":"2005","unstructured":"Bosch, J. et al. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension. Circulation 112, 1339\u20131346, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.548461 (2005).","journal-title":"Circulation"},{"key":"29958_CR29","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s00125-012-2752-5","volume":"56","author":"J Lindstrom","year":"2013","unstructured":"Lindstrom, J. et al. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia 56, 284\u2013293, https:\/\/doi.org\/10.1007\/s00125-012-2752-5 (2013).","journal-title":"Diabetologia"},{"key":"29958_CR30","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(08)60766-7","volume":"371","author":"G Li","year":"2008","unstructured":"Li, G. et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371, 1783\u20131789, https:\/\/doi.org\/10.1016\/S0140-6736(08)60766-7 (2008).","journal-title":"Lancet"},{"issue":"Suppl 1","key":"29958_CR31","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S0168-8227(09)70002-6","volume":"86","author":"A Ceriello","year":"2009","unstructured":"Ceriello, A. Hypothesis: the \u201cmetabolic memory\u201d, the new challenge of diabetes. Diabetes Res Clin Pract 86(Suppl 1), S2\u20136, https:\/\/doi.org\/10.1016\/S0168-8227(09)70002-6 (2009).","journal-title":"Diabetes Res Clin Pract"},{"key":"29958_CR32","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00125-007-0684-2","volume":"50","author":"MA Ihnat","year":"2007","unstructured":"Ihnat, M. A. et al. Reactive oxygen species mediate a cellular \u2018memory\u2019 of high glucose stress signalling. Diabetologia 50, 1523\u20131531, https:\/\/doi.org\/10.1007\/s00125-007-0684-2 (2007).","journal-title":"Diabetologia"},{"key":"29958_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1053\/j.ajkd.2004.11.012","volume":"45","author":"L Zuo","year":"2005","unstructured":"Zuo, L. et al. Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis 45, 463\u2013472, https:\/\/doi.org\/10.1053\/j.ajkd.2004.11.012 (2005).","journal-title":"Am J Kidney Dis"},{"key":"29958_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/oxfordjournals.aje.a010013","volume":"150","author":"R Clarke","year":"1999","unstructured":"Clarke, R. et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 150, 341\u2013353 (1999).","journal-title":"Am J Epidemiol"},{"key":"29958_CR35","doi-asserted-by":"publisher","first-page":"c2289","DOI":"10.1136\/bmj.c2289","volume":"340","author":"JA Hutcheon","year":"2010","unstructured":"Hutcheon, J. A., Chiolero, A. & Hanley, J. A. Random measurement error and regression dilution bias. BMJ 340, c2289, https:\/\/doi.org\/10.1136\/bmj.c2289 (2010).","journal-title":"BMJ"},{"key":"29958_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/BF03344102","volume":"29","author":"S Lim","year":"2006","unstructured":"Lim, S. et al. A rural-urban comparison of the characteristics of the metabolic syndrome by gender in Korea: the Korean Health and Genome Study (KHGS). J Endocrinol Invest 29, 313\u2013319, https:\/\/doi.org\/10.1007\/BF03344102 (2006).","journal-title":"J Endocrinol Invest"},{"key":"29958_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/ng.357","volume":"41","author":"YS Cho","year":"2009","unstructured":"Cho, Y. S. et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 41, 527\u2013534, https:\/\/doi.org\/10.1038\/ng.357 (2009).","journal-title":"Nat Genet"},{"issue":"1","key":"29958_CR38","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.27.2007.S5","volume":"27","author":"American Diabetes, A","year":"2004","unstructured":"American Diabetes, A. Diagnosis and classification of diabetes mellitus. Diabetes Care 27(1), S5\u2013S10 (2004).","journal-title":"Diabetes Care"},{"key":"29958_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3803\/EnM.2014.29.4.405","volume":"29","author":"MK Kim","year":"2014","unstructured":"Kim, M. K. et al. 2014 clinical practice guidelines for overweight and obesity in Korea. Endocrinol Metab (Seoul) 29, 405\u2013409, https:\/\/doi.org\/10.3803\/EnM.2014.29.4.405 (2014).","journal-title":"Endocrinol Metab (Seoul)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29958-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29958-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29958-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:39:03Z","timestamp":1671611943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29958-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,16]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["29958"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-29958-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,16]]},"assertion":[{"value":"2 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12237"}}